Literature DB >> 21953814

Visual misperceptions and hallucinations in Parkinson's disease: dysfunction of attentional control networks?

James M Shine1, Glenda M Halliday, Sharon L Naismith, Simon J G Lewis.   

Abstract

Visual misperceptions and hallucinations are a major cause of distress in patients with Parkinson's disease (PD), particularly in the advanced stages of the condition. Recent work has provided a framework for understanding the pathogenesis of these symptoms, implicating impairments from the retina to the integration of external information with preformed internal images. In this article, we propose a novel hypothesis that attempts to explain the presence of visual misperceptions and hallucinations in PD through the aberrant coordination of complimentary yet competing neural networks. We propose that hallucinations in PD reflect the relative inability to recruit activation in the dorsal attention network in the presence of an ambiguous percept, leading to overreliance on default mode network processing and salience arising from the ventral attention network. This inability is proposed to stem from improper function across cortical and subcortical structures secondary to the presence of Lewy body pathology. This hypothesis may be empirically tested by the use of targeted cognitive paradigms. In turn, this may assist our understanding of the pathophysiological mechanisms and cognitive processes contributing to visual misperceptions and hallucinations and ultimately may inform more effective treatment strategies for this troubling symptom.
Copyright © 2011 Movement Disorder Society.

Entities:  

Mesh:

Year:  2011        PMID: 21953814     DOI: 10.1002/mds.23896

Source DB:  PubMed          Journal:  Mov Disord        ISSN: 0885-3185            Impact factor:   10.338


  53 in total

1.  The role of dysfunctional attentional control networks in visual misperceptions in Parkinson's disease.

Authors:  James M Shine; Glenda M Halliday; Moran Gilat; Elie Matar; Samuel J Bolitho; Maria Carlos; Sharon L Naismith; Simon J G Lewis
Journal:  Hum Brain Mapp       Date:  2013-06-13       Impact factor: 5.038

2.  Advances in the treatment of visual hallucinations in neurodegenerative diseases.

Authors:  Daniel Collerton; John-Paul Taylor
Journal:  Future Neurol       Date:  2013-07

3.  Deviations in cortex sulcation associated with visual hallucinations in schizophrenia.

Authors:  A Cachia; A Amad; J Brunelin; M-O Krebs; M Plaze; P Thomas; R Jardri
Journal:  Mol Psychiatry       Date:  2014-10-28       Impact factor: 15.992

Review 4.  Cognitive and behavioral disorders in Parkinson's disease: an update. II: behavioral disorders.

Authors:  Luigi Trojano; Costanza Papagno
Journal:  Neurol Sci       Date:  2017-10-16       Impact factor: 3.307

5.  Visuoperceptive region atrophy independent of cognitive status in patients with Parkinson's disease with hallucinations.

Authors:  Jennifer G Goldman; Glenn T Stebbins; Vy Dinh; Bryan Bernard; Doug Merkitch; Leyla deToledo-Morrell; Christopher G Goetz
Journal:  Brain       Date:  2014-01-29       Impact factor: 13.501

6.  Imagine that: elevated sensory strength of mental imagery in individuals with Parkinson's disease and visual hallucinations.

Authors:  James M Shine; Rebecca Keogh; Claire O'Callaghan; Alana J Muller; Simon J G Lewis; Joel Pearson
Journal:  Proc Biol Sci       Date:  2015-01-07       Impact factor: 5.349

7.  Dual tasking in Parkinson's disease: Cognitive consequences while walking.

Authors:  Robert D Salazar; Xiaolin Ren; Terry D Ellis; Noor Toraif; Olivier J Barthelemy; Sandy Neargarder; Alice Cronin-Golomb
Journal:  Neuropsychology       Date:  2017-04-17       Impact factor: 3.295

Review 8.  Pain and analgesia: the value of salience circuits.

Authors:  David Borsook; Robert Edwards; Igor Elman; Lino Becerra; Jon Levine
Journal:  Prog Neurobiol       Date:  2013-03-07       Impact factor: 11.685

9.  Dysfunction in attentional processing in patients with Parkinson's disease and visual hallucinations.

Authors:  Julie M Hall; Claire O'Callaghan; James M Shine; Alana J Muller; Joseph R Phillips; Courtney C Walton; Simon J G Lewis; Ahmed A Moustafa
Journal:  J Neural Transm (Vienna)       Date:  2016-03-03       Impact factor: 3.575

10.  Validation of the Psychosis and Hallucinations Questionnaire in Non-demented Patients with Parkinson's Disease.

Authors:  James M Shine; Joanna M Z Mills; Jessica Qiu; Claire O'Callaghan; Zoe Terpening; Glenda M Halliday; Sharon L Naismith; Simon J G Lewis
Journal:  Mov Disord Clin Pract       Date:  2015-03-16
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.